-
(6S)-1-[(4-amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-1H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid trifluoroacetic acid hydrate
-
ChemBase ID:
154059
-
Molecular Formular:
C31H31F3N4O6
-
Molecular Mass:
612.5962496
-
Monoisotopic Mass:
612.21956939
-
SMILES and InChIs
SMILES:
Cc1cc(ccc1N)Cn1cnc2c1C[C@H](N(C2)C(=O)C(c1ccccc1)c1ccccc1)C(=O)O.C(=O)(C(F)(F)F)O.O
Canonical SMILES:
OC(=O)C(F)(F)F.OC(=O)[C@@H]1Cc2c(CN1C(=O)C(c1ccccc1)c1ccccc1)ncn2Cc1ccc(c(c1)C)N.O
InChI:
InChI=1S/C29H28N4O3.C2HF3O2.H2O/c1-19-14-20(12-13-23(19)30)16-32-18-31-24-17-33(26(29(35)36)15-25(24)32)28(34)27(21-8-4-2-5-9-21)22-10-6-3-7-11-22;3-2(4,5)1(6)7;/h2-14,18,26-27H,15-17,30H2,1H3,(H,35,36);(H,6,7);1H2/t26-;;/m0../s1
InChIKey:
IRRZMYRIDIBBQG-ROPHLPQBSA-N
-
Cite this record
CBID:154059 http://www.chembase.cn/molecule-154059.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
(6S)-1-[(4-amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-1H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid trifluoroacetic acid hydrate
|
|
|
|
|
IUPAC Traditional name
|
|
(6S)-1-[(4-amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-4H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid trifluoroacetic acid hydrate
|
|
|
|
|
Synonyms
|
|
(S)-1-[(4-Amino-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-Imidazo[4,5-c]pyridine-6-carboxylic acid trifluoroacetate salt hydrate
|
|
S-(+)-PD 123177 trifluoroacetate salt hydrate
|
|
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
3.7144482
|
H Acceptors
|
5
|
H Donor
|
2
|
LogD (pH = 5.5)
|
2.2711158
|
LogD (pH = 7.4)
|
0.94832814
|
Log P
|
2.3224716
|
Molar Refractivity
|
139.0742 cm3
|
Polarizability
|
52.61909 Å3
|
Polar Surface Area
|
101.45 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
P5749
|
Biochem/physiol Actions S-(+)-PD 123177 is selective AT2 angiotensin receptor antagonist. The angiotensin AT2 receptor is an atypical seven transmembrane domain receptor that is coupled to activation of tyrosine phosphatase and inhibition of MAP kinase, and does not undergo agonist-induced internalization. An investigation of the occurrence and nature of AT2 receptor phosphorylation revealed that phorbol ester-induced activation of protein kinase C (PKC) in HA-AT2 receptor-expressing COS-7 cells caused rapid and specific phosphorylation of a single residue (Ser354) located in the cytoplasmic tail of the receptor. Agonist activation of AT2 receptors by angiotensin II (Ang II) also caused rapid PKC-dependent phosphorylation of Ser354 that was prevented by the AT2 antagonist, S-(+)-PD 123177, and by inhibitors of PKC. In cells coexpressing AT1 and AT2 receptors, Ang II-induced phosphorylation of the AT2 receptor was reduced by S-(+)-PD 123177 and abolished by treatment with both antagonists or with PKC inhibitors. These findings indicate that the AT2 receptor is rapidly phosphorylated via PKC during homologous activation by Ang II, and also undergoes heterologous PKC-dependent phosphorylation during activation of the AT1 receptor. |
PATENTS
PATENTS
PubChem Patent
Google Patent